Melanogenesis Pathway Research

An area of ongoing dermatological research is represented by the biochemical pathway of melanin production. Examination of the cellular and molecular mechanisms involved in pigment synthesis is required for understanding this process.

UV-Induced Melanogenesis Pathway

Involving the p53 gene pathway, a cellular response is initiated by ultraviolet radiation. Through a well-characterized biochemical cascade, a documented cellular response to DNA damage is represented.


When UV radiation causes DNA lesions in epidermal cells, activating p53 protein, the process begins. Production of proopiomelanocortin (POMC) is triggered, which is subsequently cleaved into several peptide products including alpha-melanocyte-stimulating hormone (α-MSH).


On melanocyte surfaces to melanocortin 1 receptor (MC1R), α-MSH binds, initiating a signaling cascade that affects melanin synthesis. Through well-documented photochemical mechanisms, the resulting melanin absorbs UV light.

Melanocortin Receptor System

To investigation of melanocortin receptors and their endogenous ligands, research into melanogenesis has led.
α-MSH
MC1R is activated by alpha-melanocyte-stimulating hormone, an endogenous peptide. In pigmentation pathways it serves as a key regulator and in various neural signaling systems also participates.
Dihydroxyacetone (DHA)
(Not a peptide) as the active ingredient in many topical cosmetic products, DHA serves as a carbohydrate compound. Through the Maillard reaction with amino acids, it interacts, producing colored compounds called melanoidins.
Melanocortin System Analogs
For laboratory investigation, various synthetic analogs of α-MSH have been developed at research institutions. These include:

  • Afamelanotide (Melanotan I): Developed at the University of Arizona, a synthetic analog
  • MT-2: With broader receptor binding profiles, a derivative
  • PT-141 (Bremelanotide): With different receptor affinity patterns, a metabolite
    For their receptor binding characteristics and selectivity profiles across melanocortin receptor subtypes (MC1R through MC5R), these compounds are studied.

References:

  • Chen, H., Weng, Q. Y., & Fisher, D. E. (2014). UV signaling pathways. J Invest Dermatol, 134(8), 2080-2085.
  • York, D. A., et al. (2011). Melanocortin receptor distribution. Pharmacol Biochem Behav, 98(1), 112-119.

NOTICE REGARDING RESEARCH MATERIALS: All content and materials available on this website are for informational purposes only. The compounds supplied by this entity are provided exclusively for controlled, in vitro scientific inquiry and laboratory use. These compounds are not formulated or sold as drugs, dietary supplements, or cosmetic products and are not intended for any clinical application in humans or animals. Any use outside of a laboratory research setting is strictly prohibited.

BOOST YOUR RESEARCH NOW
$25 OFF YOUR FIRST ORDER

ampetide

$25 Off

HAS BEEN APPLIED

TO YOUR FIRST ORDER